It is well known that rare LPL mutations cause marked dyslipidemias (e.g., familial LPL deficiency with chylomicronemia [13], at least some of which are known to be involved in the development of premature atherosclerosis [13]. This evidence concerns the gene LPL and metabolic syndrome.